| Internal Health And Medical Services Llc | |
|
2189 West St Ste 2 Germantown TN 38138-3884 | |
| (901) 496-0167 | |
| (901) 421-5967 |
| Full Name | Internal Health And Medical Services Llc |
|---|---|
| Speciality | Family Medicine |
| Location | 2189 West St Ste 2, Germantown, Tennessee |
| Authorized Official Name and Position | Margaret Henderson-lee (CHIEF MEDICAL OFFICE) |
| Authorized Official Contact | 9014960167 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Internal Health And Medical Services Llc 2189 West St Ste 2 Germantown TN 38138-3884 Ph: (901) 496-0167 | Internal Health And Medical Services Llc 2189 West St Ste 2 Germantown TN 38138-3884 Ph: (901) 496-0167 |
| NPI Number | 1215569207 |
|---|---|
| Provider Enumeration Date | 02/07/2020 |
| Last Update Date | 02/05/2024 |
| Medicare PECOS PAC ID | 9436589850 |
|---|---|
| Medicare Enrollment ID | O20200424001984 |
News Archive
Misonix, Inc. has announced today that its majority-owned Sonora Medical Systems, Inc. subsidiary has received the first of three patents filed for its FirstCall 2000 ultrasound probe-testing device. The patent enforces the FirstCall device's unique process for testing ultrasound probes on site without requiring the ultrasonic system to be in operation.
Deep Venous Thrombosis (DVT) is a serious condition that involves the formation of a blood clot inside of a deep vein usually in the legs. A patient with DVT is typically treated with anticoagulants (blood thinners) however researchers have found that image-guided interventional radiology procedures may play a more central role in the long-term treatment of DVT, according to a study published in the October issue of the American Journal of Roentgenology (AJR).
Exelixis, Inc. today announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute's Cancer Therapy Evaluation Program (CTEP) for further evaluation of cabozantinib, Exelixis' lead compound, in a variety of solid tumors.
A new treatment may help patients with a chronic kidney condition that can also lead to heart problems and premature death, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
Pfizer Inc.'s new investigational microsphere formulation of azithromycin, which is dosed as a one-time-only oral antibiotic, is comparable to other frequently prescribed treatments for some of the most common respiratory tract infections in adult patients.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215569207 | NPI | - | NPPES |
| 271886762 | Medicaid | AR | |
| Q055459 | Medicaid | TN |
| Provider Name | Edward R Davis |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1346242203 PECOS PAC ID: 2961527841 Enrollment ID: I20100915000915 |
News Archive
Misonix, Inc. has announced today that its majority-owned Sonora Medical Systems, Inc. subsidiary has received the first of three patents filed for its FirstCall 2000 ultrasound probe-testing device. The patent enforces the FirstCall device's unique process for testing ultrasound probes on site without requiring the ultrasonic system to be in operation.
Deep Venous Thrombosis (DVT) is a serious condition that involves the formation of a blood clot inside of a deep vein usually in the legs. A patient with DVT is typically treated with anticoagulants (blood thinners) however researchers have found that image-guided interventional radiology procedures may play a more central role in the long-term treatment of DVT, according to a study published in the October issue of the American Journal of Roentgenology (AJR).
Exelixis, Inc. today announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute's Cancer Therapy Evaluation Program (CTEP) for further evaluation of cabozantinib, Exelixis' lead compound, in a variety of solid tumors.
A new treatment may help patients with a chronic kidney condition that can also lead to heart problems and premature death, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
Pfizer Inc.'s new investigational microsphere formulation of azithromycin, which is dosed as a one-time-only oral antibiotic, is comparable to other frequently prescribed treatments for some of the most common respiratory tract infections in adult patients.
› Verified 5 days ago
| Provider Name | Margaret Henderson-lee |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1952629180 PECOS PAC ID: 7315133311 Enrollment ID: I20101201001084 |
News Archive
Misonix, Inc. has announced today that its majority-owned Sonora Medical Systems, Inc. subsidiary has received the first of three patents filed for its FirstCall 2000 ultrasound probe-testing device. The patent enforces the FirstCall device's unique process for testing ultrasound probes on site without requiring the ultrasonic system to be in operation.
Deep Venous Thrombosis (DVT) is a serious condition that involves the formation of a blood clot inside of a deep vein usually in the legs. A patient with DVT is typically treated with anticoagulants (blood thinners) however researchers have found that image-guided interventional radiology procedures may play a more central role in the long-term treatment of DVT, according to a study published in the October issue of the American Journal of Roentgenology (AJR).
Exelixis, Inc. today announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute's Cancer Therapy Evaluation Program (CTEP) for further evaluation of cabozantinib, Exelixis' lead compound, in a variety of solid tumors.
A new treatment may help patients with a chronic kidney condition that can also lead to heart problems and premature death, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
Pfizer Inc.'s new investigational microsphere formulation of azithromycin, which is dosed as a one-time-only oral antibiotic, is comparable to other frequently prescribed treatments for some of the most common respiratory tract infections in adult patients.
› Verified 5 days ago
| Provider Name | Linda Taylor |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1174071633 PECOS PAC ID: 9931483872 Enrollment ID: I20170221001946 |
News Archive
Misonix, Inc. has announced today that its majority-owned Sonora Medical Systems, Inc. subsidiary has received the first of three patents filed for its FirstCall 2000 ultrasound probe-testing device. The patent enforces the FirstCall device's unique process for testing ultrasound probes on site without requiring the ultrasonic system to be in operation.
Deep Venous Thrombosis (DVT) is a serious condition that involves the formation of a blood clot inside of a deep vein usually in the legs. A patient with DVT is typically treated with anticoagulants (blood thinners) however researchers have found that image-guided interventional radiology procedures may play a more central role in the long-term treatment of DVT, according to a study published in the October issue of the American Journal of Roentgenology (AJR).
Exelixis, Inc. today announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute's Cancer Therapy Evaluation Program (CTEP) for further evaluation of cabozantinib, Exelixis' lead compound, in a variety of solid tumors.
A new treatment may help patients with a chronic kidney condition that can also lead to heart problems and premature death, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
Pfizer Inc.'s new investigational microsphere formulation of azithromycin, which is dosed as a one-time-only oral antibiotic, is comparable to other frequently prescribed treatments for some of the most common respiratory tract infections in adult patients.
› Verified 5 days ago
| Provider Name | Tina Hollis |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1043724347 PECOS PAC ID: 4880958750 Enrollment ID: I20180430001523 |
News Archive
Misonix, Inc. has announced today that its majority-owned Sonora Medical Systems, Inc. subsidiary has received the first of three patents filed for its FirstCall 2000 ultrasound probe-testing device. The patent enforces the FirstCall device's unique process for testing ultrasound probes on site without requiring the ultrasonic system to be in operation.
Deep Venous Thrombosis (DVT) is a serious condition that involves the formation of a blood clot inside of a deep vein usually in the legs. A patient with DVT is typically treated with anticoagulants (blood thinners) however researchers have found that image-guided interventional radiology procedures may play a more central role in the long-term treatment of DVT, according to a study published in the October issue of the American Journal of Roentgenology (AJR).
Exelixis, Inc. today announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute's Cancer Therapy Evaluation Program (CTEP) for further evaluation of cabozantinib, Exelixis' lead compound, in a variety of solid tumors.
A new treatment may help patients with a chronic kidney condition that can also lead to heart problems and premature death, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
Pfizer Inc.'s new investigational microsphere formulation of azithromycin, which is dosed as a one-time-only oral antibiotic, is comparable to other frequently prescribed treatments for some of the most common respiratory tract infections in adult patients.
› Verified 5 days ago
| Provider Name | Barry Workman |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1972543148 PECOS PAC ID: 9739420852 Enrollment ID: I20190417002060 |
News Archive
Misonix, Inc. has announced today that its majority-owned Sonora Medical Systems, Inc. subsidiary has received the first of three patents filed for its FirstCall 2000 ultrasound probe-testing device. The patent enforces the FirstCall device's unique process for testing ultrasound probes on site without requiring the ultrasonic system to be in operation.
Deep Venous Thrombosis (DVT) is a serious condition that involves the formation of a blood clot inside of a deep vein usually in the legs. A patient with DVT is typically treated with anticoagulants (blood thinners) however researchers have found that image-guided interventional radiology procedures may play a more central role in the long-term treatment of DVT, according to a study published in the October issue of the American Journal of Roentgenology (AJR).
Exelixis, Inc. today announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute's Cancer Therapy Evaluation Program (CTEP) for further evaluation of cabozantinib, Exelixis' lead compound, in a variety of solid tumors.
A new treatment may help patients with a chronic kidney condition that can also lead to heart problems and premature death, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
Pfizer Inc.'s new investigational microsphere formulation of azithromycin, which is dosed as a one-time-only oral antibiotic, is comparable to other frequently prescribed treatments for some of the most common respiratory tract infections in adult patients.
› Verified 5 days ago
| Provider Name | Teadra Pennycooke |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1649746249 PECOS PAC ID: 5991041741 Enrollment ID: I20211026000404 |
News Archive
Misonix, Inc. has announced today that its majority-owned Sonora Medical Systems, Inc. subsidiary has received the first of three patents filed for its FirstCall 2000 ultrasound probe-testing device. The patent enforces the FirstCall device's unique process for testing ultrasound probes on site without requiring the ultrasonic system to be in operation.
Deep Venous Thrombosis (DVT) is a serious condition that involves the formation of a blood clot inside of a deep vein usually in the legs. A patient with DVT is typically treated with anticoagulants (blood thinners) however researchers have found that image-guided interventional radiology procedures may play a more central role in the long-term treatment of DVT, according to a study published in the October issue of the American Journal of Roentgenology (AJR).
Exelixis, Inc. today announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute's Cancer Therapy Evaluation Program (CTEP) for further evaluation of cabozantinib, Exelixis' lead compound, in a variety of solid tumors.
A new treatment may help patients with a chronic kidney condition that can also lead to heart problems and premature death, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
Pfizer Inc.'s new investigational microsphere formulation of azithromycin, which is dosed as a one-time-only oral antibiotic, is comparable to other frequently prescribed treatments for some of the most common respiratory tract infections in adult patients.
› Verified 5 days ago
| Provider Name | Wendy Powell |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1205488087 PECOS PAC ID: 5395134969 Enrollment ID: I20211119002249 |
News Archive
Misonix, Inc. has announced today that its majority-owned Sonora Medical Systems, Inc. subsidiary has received the first of three patents filed for its FirstCall 2000 ultrasound probe-testing device. The patent enforces the FirstCall device's unique process for testing ultrasound probes on site without requiring the ultrasonic system to be in operation.
Deep Venous Thrombosis (DVT) is a serious condition that involves the formation of a blood clot inside of a deep vein usually in the legs. A patient with DVT is typically treated with anticoagulants (blood thinners) however researchers have found that image-guided interventional radiology procedures may play a more central role in the long-term treatment of DVT, according to a study published in the October issue of the American Journal of Roentgenology (AJR).
Exelixis, Inc. today announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute's Cancer Therapy Evaluation Program (CTEP) for further evaluation of cabozantinib, Exelixis' lead compound, in a variety of solid tumors.
A new treatment may help patients with a chronic kidney condition that can also lead to heart problems and premature death, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
Pfizer Inc.'s new investigational microsphere formulation of azithromycin, which is dosed as a one-time-only oral antibiotic, is comparable to other frequently prescribed treatments for some of the most common respiratory tract infections in adult patients.
› Verified 5 days ago
| Provider Name | Lenora Diane Downs |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1790437895 PECOS PAC ID: 8325431406 Enrollment ID: I20220214001358 |
News Archive
Misonix, Inc. has announced today that its majority-owned Sonora Medical Systems, Inc. subsidiary has received the first of three patents filed for its FirstCall 2000 ultrasound probe-testing device. The patent enforces the FirstCall device's unique process for testing ultrasound probes on site without requiring the ultrasonic system to be in operation.
Deep Venous Thrombosis (DVT) is a serious condition that involves the formation of a blood clot inside of a deep vein usually in the legs. A patient with DVT is typically treated with anticoagulants (blood thinners) however researchers have found that image-guided interventional radiology procedures may play a more central role in the long-term treatment of DVT, according to a study published in the October issue of the American Journal of Roentgenology (AJR).
Exelixis, Inc. today announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute's Cancer Therapy Evaluation Program (CTEP) for further evaluation of cabozantinib, Exelixis' lead compound, in a variety of solid tumors.
A new treatment may help patients with a chronic kidney condition that can also lead to heart problems and premature death, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
Pfizer Inc.'s new investigational microsphere formulation of azithromycin, which is dosed as a one-time-only oral antibiotic, is comparable to other frequently prescribed treatments for some of the most common respiratory tract infections in adult patients.
› Verified 5 days ago
| Provider Name | Tonya Dixon |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1558664854 PECOS PAC ID: 5395122360 Enrollment ID: I20220512000833 |
News Archive
Misonix, Inc. has announced today that its majority-owned Sonora Medical Systems, Inc. subsidiary has received the first of three patents filed for its FirstCall 2000 ultrasound probe-testing device. The patent enforces the FirstCall device's unique process for testing ultrasound probes on site without requiring the ultrasonic system to be in operation.
Deep Venous Thrombosis (DVT) is a serious condition that involves the formation of a blood clot inside of a deep vein usually in the legs. A patient with DVT is typically treated with anticoagulants (blood thinners) however researchers have found that image-guided interventional radiology procedures may play a more central role in the long-term treatment of DVT, according to a study published in the October issue of the American Journal of Roentgenology (AJR).
Exelixis, Inc. today announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute's Cancer Therapy Evaluation Program (CTEP) for further evaluation of cabozantinib, Exelixis' lead compound, in a variety of solid tumors.
A new treatment may help patients with a chronic kidney condition that can also lead to heart problems and premature death, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
Pfizer Inc.'s new investigational microsphere formulation of azithromycin, which is dosed as a one-time-only oral antibiotic, is comparable to other frequently prescribed treatments for some of the most common respiratory tract infections in adult patients.
› Verified 5 days ago
| Provider Name | Natalie Paige |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1962139030 PECOS PAC ID: 3870969447 Enrollment ID: I20221024000220 |
News Archive
Misonix, Inc. has announced today that its majority-owned Sonora Medical Systems, Inc. subsidiary has received the first of three patents filed for its FirstCall 2000 ultrasound probe-testing device. The patent enforces the FirstCall device's unique process for testing ultrasound probes on site without requiring the ultrasonic system to be in operation.
Deep Venous Thrombosis (DVT) is a serious condition that involves the formation of a blood clot inside of a deep vein usually in the legs. A patient with DVT is typically treated with anticoagulants (blood thinners) however researchers have found that image-guided interventional radiology procedures may play a more central role in the long-term treatment of DVT, according to a study published in the October issue of the American Journal of Roentgenology (AJR).
Exelixis, Inc. today announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute's Cancer Therapy Evaluation Program (CTEP) for further evaluation of cabozantinib, Exelixis' lead compound, in a variety of solid tumors.
A new treatment may help patients with a chronic kidney condition that can also lead to heart problems and premature death, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
Pfizer Inc.'s new investigational microsphere formulation of azithromycin, which is dosed as a one-time-only oral antibiotic, is comparable to other frequently prescribed treatments for some of the most common respiratory tract infections in adult patients.
› Verified 5 days ago
News Archive
Misonix, Inc. has announced today that its majority-owned Sonora Medical Systems, Inc. subsidiary has received the first of three patents filed for its FirstCall 2000 ultrasound probe-testing device. The patent enforces the FirstCall device's unique process for testing ultrasound probes on site without requiring the ultrasonic system to be in operation.
Deep Venous Thrombosis (DVT) is a serious condition that involves the formation of a blood clot inside of a deep vein usually in the legs. A patient with DVT is typically treated with anticoagulants (blood thinners) however researchers have found that image-guided interventional radiology procedures may play a more central role in the long-term treatment of DVT, according to a study published in the October issue of the American Journal of Roentgenology (AJR).
Exelixis, Inc. today announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute's Cancer Therapy Evaluation Program (CTEP) for further evaluation of cabozantinib, Exelixis' lead compound, in a variety of solid tumors.
A new treatment may help patients with a chronic kidney condition that can also lead to heart problems and premature death, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
Pfizer Inc.'s new investigational microsphere formulation of azithromycin, which is dosed as a one-time-only oral antibiotic, is comparable to other frequently prescribed treatments for some of the most common respiratory tract infections in adult patients.
› Verified 5 days ago
Biomechaniks Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3100 Village Shops Dr, Germantown, TN 38138 Phone: 901-620-6127 Fax: 901-620-6124 | |
Ihms Healthcare Incorporated Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2189 West St Ste 2, Germantown, TN 38138 Phone: 901-421-5174 Fax: 901-421-5967 | |
Germantown Back Pain Relief Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2018 Germantown Rd S, Germantown, TN 38138 Phone: 901-754-8880 Fax: 901-754-8883 | |
Geriatrics & Palliative Care Pllc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 7820 Walking Horse Cir, Germantown, TN 38138 Phone: 901-279-4360 | |
Germantown Internal Medicine Associates,pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 7645 Wolf River Cir, Suite 202, Germantown, TN 38138 Phone: 901-348-6487 Fax: 901-791-0338 | |
Internal Health And Medical Services Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2158 Judicial Dr, Germantown, TN 38138 Phone: 901-421-5174 | |
Lunceford Family Health Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1920 Kirby Pkwy, Suite 100, Germantown, TN 38138 Phone: 901-751-9909 Fax: 901-751-0455 |